Niina Piippo

883 citations
24 papers · 745 indexed · h-index 15
Topics
Inflammasome and immune disorders (15 papers)Retinal Diseases and Treatments (11 papers)Heme Oxygenase-1 and Carbon Monoxide (10 papers)
Partner nations
FinlandNorwayHungary

In The Last Decade

Niina Piippo

24 papers receiving 736 citations

Peers

Niina Piippo
Comparison fields: 5 of 84
  • Molecular Biology 419
  • Ophthalmology 313
  • Immunology 115
  • Epidemiology 90
  • Radiology, Nuclear Medicine and Imaging 69
Replace Maria Hytti with:
Maria Hytti Finland
Eveliina Korhonen Finland
Rosa Maisto Italy
Ramaprasad Ravichandra Talahalli India
Mohammad Shoeb United States
Kévin Ragot France
Keri A. Kles United States
Li Gao China
Shanshan Wu China
Niina Piippo relative to Maria Hytti Finland Maria Hytti's profile →
Citations per field
00.5×1.5×
Maria Hytti · 1×
Citations per year

Countries citing papers authored by Niina Piippo

Since Specialization
Citations

This map shows the geographic impact of Niina Piippo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niina Piippo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niina Piippo more than expected).

Fields of papers citing papers by Niina Piippo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niina Piippo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niina Piippo. The network helps show where Niina Piippo may publish in the future.

Co-authorship network of co-authors of Niina Piippo

This figure shows the co-authorship network connecting the top 25 collaborators of Niina Piippo. A scholar is included among the top collaborators of Niina Piippo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niina Piippo. Niina Piippo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 13
4 16
5 14
6 21
7 19
8 14
9 58
10 86
11 42
12 14
13 57
14 20
15 79
16 1
17 55
18 1
19 24
20 56

About Niina Piippo

Niina Piippo is a scholar working on Ophthalmology, Clinical Biochemistry and Molecular Biology, having authored 24 papers that have together received 745 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (15 papers), Retinal Diseases and Treatments (11 papers) and Heme Oxygenase-1 and Carbon Monoxide (10 papers). The work is most often cited by research in Ophthalmology (313 citations), Clinical Biochemistry (62 citations) and Neurology (67 citations). Niina Piippo has collaborated with scholars based in Finland, Norway and Hungary. Frequent co-authors include Kai Kaarniranta, Anu Kauppinen, Maria Hytti, Eveliina Korhonen, Kati Kinnunen, Paavo Honkakoski, Goran Petrovski, Sirpa Loukovaara, Antero Salminen and Heli Skottman. Their work appears in journals such as Scientific Reports, The FASEB Journal and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026